| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.13 | 0.04 |